Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Deximune 100mg capsules
0802020G0BEACAD
|
Deximune | Ciclosporin | Malignant Disease and Immunosuppression | 221 |
|
Methotrexate 25mg/1ml inj pre-filled syringes
0801030P0AAFGFG
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 218 |
|
Methotrexate 20mg/0.8ml inj pre-filled syringes
0801030P0AAFEFE
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 217 |
|
Leuprorelin 11.25mg implant pre-filled syringes
0803042N0AAAFAF
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | 215 |
|
Lanreotide 60mg/0.5ml inj pre-filled syringes
0803043P0AAAEAE
|
Lanreotide | Lanreotide | Malignant Disease and Immunosuppression | 214 |
|
Hydroxycarbamide 500mg/5ml oral solution sugar free
0801050P0AAAEAE
|
Hydroxycarbamide | Hydroxycarbamide | Malignant Disease and Immunosuppression | 209 |
|
Myfenax 250mg capsules
0802010M0BCABAA
|
Myfenax | Mycophenolate mofetil | Malignant Disease and Immunosuppression | 204 |
|
Somatuline Autogel 120mg/0.5ml inj pfs with safety system
0803043P0BBAGAD
|
Somatuline | Lanreotide | Malignant Disease and Immunosuppression | 202 |
|
Deximune 25mg capsules
0802020G0BEAAAC
|
Deximune | Ciclosporin | Malignant Disease and Immunosuppression | 199 |
|
Capimune 100mg capsules
0802020G0BFACAD
|
Capimune | Ciclosporin | Malignant Disease and Immunosuppression | 197 |
|
Sandostatin LAR 20mg inj vials
0803043N0BBAGAG
|
Sandostatin | Octreotide acetate | Malignant Disease and Immunosuppression | 197 |
|
Sirolimus 500microgram tablets
0802020U0AAAFAF
|
Sirolimus | Sirolimus | Malignant Disease and Immunosuppression | 187 |
|
Tacrolimus 500microgram capsules
0802020T0AAAFAF
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 186 |
|
Relugolix 120mg tablets
0803042X0AAAAAA
|
Relugolix | Relugolix | Malignant Disease and Immunosuppression | 179 |
|
Capimune 50mg capsules
0802020G0BFABAF
|
Capimune | Ciclosporin | Malignant Disease and Immunosuppression | 174 |
|
Provera 400mg tablets
0803020H0BDADAF
|
Provera (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 169 |
|
Neoral 100mg/ml oral solution
0802020G0BCAAAG
|
Neoral | Ciclosporin | Malignant Disease and Immunosuppression | 167 |
|
Lanreotide 90mg/0.5ml inj pre-filled syringes
0803043P0AAAFAF
|
Lanreotide | Lanreotide | Malignant Disease and Immunosuppression | 158 |
|
Hanixol 50mg tablets
0801030L0BDAAAA
|
Hanixol | Mercaptopurine | Malignant Disease and Immunosuppression | 155 |
|
Modigraf 0.2mg granules for oral suspension sachets
0802020T0BDAAAV
|
Modigraf | Tacrolimus | Malignant Disease and Immunosuppression | 149 |
|
Envarsus 1mg modified-release tablets
0802020T0BJAABC
|
Envarsus | Tacrolimus | Malignant Disease and Immunosuppression | 148 |
|
Methotrexate 17.5mg/0.7ml inj pre-filled disposable devices
0801030P0AAFRFR
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 143 |
|
Neoral 10mg capsules
0802020G0BCAEAH
|
Neoral | Ciclosporin | Malignant Disease and Immunosuppression | 139 |
|
Methotrexate 15mg/0.6ml inj pre-filled syringes
0801030P0AAFKFK
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 138 |
|
Mercaptopurine 20mg/ml oral suspension
0801030L0AAAQAQ
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | 135 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.